These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 819932)

  • 41. On the immune precipitation of phosphorylcholine lipids with TEPC 15 mouse myeloma protein and with anti-lecithin sera from guinea pigs.
    Niedieck B; Kuck U; Gardemin H
    Immunochemistry; 1978 Jul; 15(7):471-5. PubMed ID: 711245
    [No Abstract]   [Full Text] [Related]  

  • 42. Clonal diversity, somatic mutation, and immune memory to phosphocholine-keyhole limpet hemocyanin.
    Stenzel-Poore MP; Rittenberg MB
    J Immunol; 1989 Dec; 143(12):4123-33. PubMed ID: 2512351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural evidence for independent joining region gene in immunoglobulin heavy chains from anti-galactan myeloma proteins and its potential role in generating diversity in complementarity-determining regions.
    Rao DN; Rudikoff S; Krutzsch H; Potter M
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2890-4. PubMed ID: 111245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predominance of the prototypic T15 anti-phosphorylcholine junctional sequence in neonatal pre-B cells.
    Feeney AJ
    J Immunol; 1991 Dec; 147(12):4343-50. PubMed ID: 1753104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance studies of the binding site interactions between phosphorylcholine and specific mouse myeloma immunoglobulin.
    Goetze AM; Richards JH
    Biochemistry; 1977 Jan; 16(2):228-32. PubMed ID: 556944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allelic forms of anti-phosphorylcholine antibodies.
    Lieberman R; Rudikoff S; Humphrey W; Potter M
    J Immunol; 1981 Jan; 126(1):172-6. PubMed ID: 7451965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deletion in HCDR3 rescues T15 antibody mutants from a secretion defect caused by mutations in HCDR2.
    Martin TM; Kowalczyk C; Stevens S; Wiens GD; Stenzel-Poore MP; Rittenberg MB
    J Immunol; 1996 Nov; 157(10):4341-6. PubMed ID: 8906808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Somatic diversification is required to generate the V kappa genes of MOPC 511 and MOPC 167 myeloma proteins.
    Gershenfeld HK; Tsukamoto A; Weissman IL; Joho R
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7674-8. PubMed ID: 6801657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Defective secretion of an immunoglobulin caused by mutations in the heavy chain complementarity determining region 2.
    Chen C; Martin TM; Stevens S; Rittenberg MB
    J Exp Med; 1994 Aug; 180(2):577-86. PubMed ID: 8046334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunologic memory to phosphocholine. V. Hybridomas representative of group II antibodies utilize V kappa 1-3 gene(s).
    Todd I; Chang SP; Perlmutter RM; Aebersold R; Heusser CH; Hood L; Rittenberg MB
    J Immunol; 1984 Mar; 132(3):1556-60. PubMed ID: 6420467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T15 idiotype expression in the murine response to phosphorylcholine is actively regulated by genes linked to the Igh-C locus.
    Stall AM; Quintáns J; Loken MR
    J Immunol; 1986 Apr; 136(7):2689-96. PubMed ID: 3081651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families.
    Andres CM; Maddalena A; Hudak S; Young NM; Claflin JL
    J Exp Med; 1981 Nov; 154(5):1584-98. PubMed ID: 7299349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide.
    Kang CY; Brunck TK; Kieber-Emmons T; Blalock JE; Kohler H
    Science; 1988 May; 240(4855):1034-6. PubMed ID: 3368787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variable region sequence of the light chain from a Waldenströms IgM with specificity for phosphorylcholine.
    Riesen WF; Jaton JC
    Biochemistry; 1976 Aug; 15(17):3829-33. PubMed ID: 821524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attempts to locate residues in complementarity-determining regions of antibody combining sites that make contact with antigen.
    Kabat EA; Wu TT; Bilofsky H
    Proc Natl Acad Sci U S A; 1976 Feb; 73(2):617-9. PubMed ID: 1061162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Idiotypes of anti-phosphocholine antibodies: structural correlates.
    Maddalena A; Hudak S; Claflin JL
    Ann Immunol (Paris); 1984; 135C(1):117-22. PubMed ID: 6201128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Properties of anti-idiotypic T cell lines propagated with syngeneic B lymphocytes. I. T cells bind intact idiotypes and discriminate between the somatic idiotypic variants in a manner similar to the anti-idiotopic antibodies.
    Cerny J; Smith JS; Webb C; Tucker PW
    J Immunol; 1988 Dec; 141(11):3718-25. PubMed ID: 3263431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulatory effects of isologous anti-idiotypic antibodies on the formation of different immunoglobulin classes in the immune response to phosphorylcholine in BALB/c mice.
    Blaser K; Heusser CH
    Eur J Immunol; 1984 Jan; 14(1):93-8. PubMed ID: 6692841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of mutations and selection in antibodies to the phosphocholine-specific determinant in Proteus morganii.
    Claflin JL; George J; Dell C; Berry J
    J Immunol; 1989 Nov; 143(9):3054-63. PubMed ID: 2478633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Somatic mutation in a cultured mouse myeloma cell affects antigen binding.
    Cook WD; Rudikoff S; Giusti AM; Scharff MD
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1240-4. PubMed ID: 6803237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.